Education
Yale University, 1984, BS, MS, Molecular Biophysics & Biochemistry 1984; Rockefeller University, 1990, PhD, Molecular Cell Biology; Cornell University Medical College, 1991, MD; Harvard University, 1997, MS, Clinical Translational Research
Professional Areas
Physician scientist leader in the development of targeted and immune therapies of non-small cell lung cancer and an innovator of master protocols (beginning with the BATTLE trial and leading to the Lung MAP Master protocol) and pragmatic clinical trial designs that identify novel molecular targeting agents.
Citation
Pioneer in the development of targeted and immune-based therapies for lung cancer, revolutionizing disease treatment through master protocols and pragmatic clinical trial designs based on patient biomarkers and personalized medicine; advanced standard of care, improved patient outcomes, and enhanced clinical trial diversity.